ArticleACS nano2026
Label-Free Single Protein Dynamics Revealed by Metasurface-Enhanced Raman Spectroscopy.
Article in ACS nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
A major challenge in biomedical science is a direct observation of conformational dynamics in single proteins, interacting with drug molecules, ligands, and other biomolecules. This limitation prevents access to free-energy landscapes that are fundamental to drug binding and transport and regulation of protein functions. Existing single-molecule experimental techniques rely on labels or tethering that can perturb the free-energy landscape or lack structural resolution. Here, we present an engineered plasmonic metasurface platform that enables label-free mapping of the conformational free-energy landscapes of individual proteins using metasurface-enhanced Raman spectroscopy. With single-molecule sensitivity, we resolve the predominant secondary structures adopted by bovine serum albumin protein while interacting with various drug-like functional groups in different pH conditions. We construct the free-energy landscapes and the transition pathways that reveal interconversion probabilities between α helix and either β sheet or random coil. These results reveal insights into the cooperative role of electrostatic interactions and chemical functionality on the conformational energy landscape. Our approach establishes a platform to study protein function, drug screening and testing, and protein-ligand interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.